Projects per year
Personal profile
Specialisation
Clinical Scientist in Molecular Pathology with over 20-year track record in translational research in oncology, focusing on exploring biomarkers and their possible role in early cancer detection and/or therapy response. She is responsible for the value of clinical laboratory services by providing advanced techniques and applying molecular information to the testing of human specimens. She has wide expertise in biomarker test development and validation research related to HPV-mediated carcinogenesis.
Research interests
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Keywords
- RB Pathology
- HPV
- DNA methylation
- molecular diagnostics
- cervical screening
Network
Projects
- 1 Active
-
RISCC: Risk-based screening for cervical cancer
Berkhof, H., Meijer, C., Kroon, K., Bogaards, H., Heideman, D., Steenbergen, R., Arbyn, M., Baussano, I., Bosch, X., Clifford, G. M., Dillner, J., Elfström, K. M., Georges, D., Lehtinen, M., Pimenoff, V. N., Poljak, M., Ronco, G. & Vänskä, S.
1/11/2019 → 31/12/2024
Project: Research
-
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis
HNCIG-EPIC group, 2023, (E-pub ahead of print) In: The Lancet Oncology.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population
Ebisch, R. M. F., Rijstenberg, L. L., Soltani, G. G., van der Horst, J., Vedder, J. E. M., Hermsen, M., Bosgraaf, R. P., Massuger, L. F. A. G., Meijer, C. J. L. M., Heideman, D. A. M., van Kemenade, F. J., Melchers, W. J. G., Bekkers, R. L. M., Siebers, A. G. & Bulten, J., Nov 2022, In: Acta obstetricia et gynecologica Scandinavica. 101, 11, p. 1328-1336 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Assessing the risk of cervical neoplasia in the post-HPV vaccination era
Lehtinen, M., Pimenoff, V. N., Nedjai, B., Louvanto, K., Verhoef, L., Heideman, D. A. M., el-Zein, M., Widschwendter, M. & Dillner, J., 2022, (E-pub ahead of print) In: International journal of cancer.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access1 Citation (Scopus) -
Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study)
Kremer, W. W., Dick, S., Heideman, D. A. M., Steenbergen, R. D. M., Bleeker, M. C. G., Verhoeve, H. R., van Baal, W. M., van Trommel, N., Kenter, G. G., Meijer, C. J. L. M. & Berkhof, J., 5 May 2022, (E-pub ahead of print) In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 189, p. JCO2102433 e2102433.Research output: Contribution to journal › Article › Academic › peer-review
Open Access9 Citations (Scopus) -
Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening
Heideman, D. A. M., Valenčak, A. O. T., Doorn, S., Bonde, J., Hillemanns, P., Domjanič, G. G., Mlakar, J., Hesselink, A. T., Meijer, C. J. L. M. & Poljak, M., 1 May 2022, In: Viruses. 14, 5, 893.Research output: Contribution to journal › Article › Academic › peer-review
Open Access